AU Patent

AU2010226466A1 — Substituted nucleoside and nucleotide analogs

Assigned to Janssen Biopharma Inc · Expires 2011-10-20 · 15y expired

What this patent protects

Disclosed herein are nucleotide analogs with protected phosphates, methods of synthesizing nucleotide analogs with protected phosphates and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with the nucleotide analogs with …

USPTO Abstract

Disclosed herein are nucleotide analogs with protected phosphates, methods of synthesizing nucleotide analogs with protected phosphates and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with the nucleotide analogs with protected phosphates.

Drugs covered by this patent

Patent Metadata

Patent number
AU2010226466A1
Jurisdiction
AU
Classification
—
Expires
2011-10-20
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.